Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5159)
All Articles published online
|
Publishing Process of This Article
|
Jan 21, 2022 (publication date) through Apr 4, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Song JP, Liu XZ, Chen Q, Liu YF. High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma. World J Clin Cases 2022; 10(3): 790-801 [PMID: 35127895 DOI: 10.12998/wjcc.v10.i3.790] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i3/790.htm |
| Number | Citing Articles |
| 1 |
Mei Chen, Zhenyu Nie, Yuanhui Gao, Hui Cao, Linlin Zheng, Na Guo, Yanling Peng, Shufang Zhang. m7G regulator-mediated molecular subtypes and tumor microenvironment in kidney renal clear cell carcinoma. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.900006
|
| 2 |
Ruyin Chen, Dandan Zheng, Qiong Li, Shuaishuai Xu, Chanqi Ye, Qi Jiang, Feifei Yan, Yunlu Jia, Xiaochen Zhang, Jian Ruan. Immunotherapy of cholangiocarcinoma: Therapeutic strategies and predictive biomarkers. Cancer Letters 2022; 546: 215853 doi: 10.1016/j.canlet.2022.215853
|
| 3 |
ATIEH POURBAGHERI-SIGAROODI, FATEMEH FALLAH, MAJID MOMENY, NIMA REZAEI, DAVOOD BASHASH. Unveiling the predictive power of bacterial response-related genes signature in hepatocellular carcinoma: with bioinformatics analyses and experimental approaches. BIOCELL 2024; 48(12): 1781 doi: 10.32604/biocell.2024.055848
|
| 4 |
Pingping Yan, Yu Dong, Fenfen Zhang, Tiantian Zhen, Jiangtao Liang, Huijuan Shi, Anjia Han. Claudin18.2 expression and its clinicopathological feature in adenocarcinoma from various parts. Journal of Clinical Pathology 2024; : jcp-2023-209268 doi: 10.1136/jcp-2023-209268
|
| 5 |
Guoliang Chen, Song Li, Adong Xia, Yuelong Xing, Wenbo Liang. The Integrated Prediction of Clinical and Pathological Factors on the Prognosis of Intrahepatic Cholangiocarcinoma. The American Surgeon™ 2024; 90(6): 1481 doi: 10.1177/00031348241241730
|
| 6 |
R. Connor Chick, Samantha M. Ruff, Timothy M. Pawlik. Factors associated with prognosis and staging of intrahepatic cholangiocarcinoma. Journal of Cancer Metastasis and Treatment 2024; doi: 10.20517/2394-4722.2024.47
|
| 7 |
Fang-Ju Huang, Ye-Ying Fang, Jia-Ying Wen, Jian-Jun Li, Qian Lin, Qin-Yan Su, Yi-Yang Chen, Lei Wang, Jian-Jia Zeng, Bang-Teng Chi, Rong-Quan He, Di-Yuan Qin, Li-Hua Yang, Gang Chen. From PD-1/PD-L1 to tertiary lymphoid structures: Paving the way for precision immunotherapy in cholangiocarcinoma treatment. Human Vaccines & Immunotherapeutics 2025; 21(1) doi: 10.1080/21645515.2024.2444697
|
| 8 |
Yue Jiang, Yingquan Ye, Yi Huang, Yue Wu, Gaoxiang Wang, Zhongxuan Gui, Mengmeng Zhang, Mei Zhang. Identification and validation of a novel anoikis-related long non-coding RNA signature for pancreatic adenocarcinoma to predict the prognosis and immune response. Journal of Cancer Research and Clinical Oncology 2023; 149(16): 15069 doi: 10.1007/s00432-023-05285-x
|
| 9 |
Virag Gehl, Colm J. O’Rourke, Jesper B. Andersen. Immunogenomics of cholangiocarcinoma. Hepatology 2023; doi: 10.1097/HEP.0000000000000688
|
| 10 |
Zachary J. Brown, Satyajit Patwardhan, Joal Bean, Timothy M. Pawlik. Molecular diagnostics and biomarkers in cholangiocarcinoma. Surgical Oncology 2022; 44: 101851 doi: 10.1016/j.suronc.2022.101851
|
| 11 |
Michael H. Storandt, Peter C. Kurniali, Amit Mahipal, Zhaohui Jin. Targeted Therapies in Advanced Cholangiocarcinoma. Life 2023; 13(10): 2066 doi: 10.3390/life13102066
|